De Generic Bio-Tech Private Limited - Company Profile

It is a life sciences private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About De Generic Bio-Tech Private Limited

De Generic Bio-Tech Private Limited, a active private limited company, was established on 23 May 2011 in Hyderabad, Telangana, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U15122TG2011PTC074610. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

It upholds a active non-compliant status. Its leadership includes Venigalla Srinivas (Director), Vijay Kumar Pal (Additional Director), Sai Kumar Akella (Director). Past directors included Polugari Madubabu, Nagaraju Shiva Rama Krishnam Raju, Battula Rama Krishna. It holds ₹1.40 Cr open charges and no settled loans. Its latest AGM occurred on 09 August 2018, with the balance sheet filed on 31 March 2018. It is based at H.No : 2-23-B/129/A , Plot No- 129/A Samath Nagar , Near Mnr College, Kukatpa, Lly, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15122TG2011PTC074610

  • Registration Number

    074610

  • Incorporation Date

    23 May 2011

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2018
  • Open Charges ₹ 1.40 Cr
  • Revenue Growth **** 135.72%
  • Profit Growth **** 47.92%
  • Ebitda **** -83.33%
  • Net Worth 33.98%
  • Total Assets **** 8.32%
Company report

De Generic Bio-Tech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into De Generic Bio-Tech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at De Generic Bio-Tech Private Limited?
Current Directors
Name Designation Appointment Date Status
Venigalla Srinivas Director 23 May 2011 Current
Vijay Kumar Pal Additional Director 03 Jul 2018 Current
Sai Kumar Akella Director 23 May 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Dec 2013 Past
Pramod Abcsdd Director 17 Dec 2013 Past
Pramod Abcsdd Additional Director 03 Jul 2018 Past
Pramod Abcsdd Additional Director 26 Jun 2019 Past
Pramod Abcsdd Director 08 Mar 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of De Generic Bio-Tech.

De Generic Bio-Tech Private Limited, for the financial year ended 2014, experienced significant growth in revenue, with a 135.72% increase. The company also saw a substantial improvement in profitability, with a 47.92% increase in profit. The company's net worth Soared by an impressive increase of 33.98%.

De Generic Bio-Tech revenue growth over time
De Generic Bio-Tech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 135.72%
*******
*******
*******
*******
Revenue from Operations
*******
 135.72%
*******
*******
*******
*******
Total Assets
*******
 8.32%
*******
*******
*******
*******
Profit or Loss
*******
 47.92%
*******
*******
*******
*******
Net Worth
*******
 33.98%
*******
*******
*******
*******
EBITDA
*******
 -83.33%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of De Generic Bio-Tech?

In 2018, De Generic Bio-Tech had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹14,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 1.40 Cr
Latest Charge Details
Date Lender Amount Status
16 Apr 2016 Others ₹1.40 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at De Generic Bio-Tech?

Unlock and access historical data on people associated with De Generic Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of De Generic Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped De Generic Bio-Tech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on De Generic Bio-Tech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on De Generic Bio-Tech Private Limited last Annual general meeting of members was held on 09 Aug 2018 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Vijay Kumar Pal was appointed as a Additional Director was appointed as a Additional Director on 03 Jul 2018 & has been associated with this company since 7 years 8 months . was documented.

  • Balance Sheet

    De Generic Bio-Tech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 14.00 M with Charge ID 100033969 was registered on 16 Apr 2016. was documented.

  • Director Appointment

    The activity Venigalla Srinivas was appointed as a Director was appointed as a Director on 23 May 2011 & has been associated with this company since 14 years 9 months . was completed.

  • Director Appointment

    Progress on Sai Kumar Akella was appointed as a Director was appointed as a Director on 23 May 2011 & has been associated with this company since 14 years 9 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of De Generic Bio-Tech Private Limited?

The CIN of De Generic Bio-Tech Private Limited is U15122TG2011PTC074610.

Where is De Generic Bio-Tech Private Limited headquartered?

De Generic Bio-Tech Private Limited is headquartered at H.No : 2-23-B/129/A , Plot No- 129/A Samath Nagar , Near Mnr College, Kukatpa, Lly, Hyderabad, Telangana, 500072.

When was De Generic Bio-Tech Private Limited incorporated?

De Generic Bio-Tech Private Limited was incorporated on 23 May 2011.

Who are the current directors of De Generic Bio-Tech Private Limited?

The current directors of De Generic Bio-Tech Private Limited are

What is the primary industry of De Generic Bio-Tech Private Limited?

The primary industry of De Generic Bio-Tech Private Limited is Life Sciences.

Is De Generic Bio-Tech Private Limited a listed company?

De Generic Bio-Tech Private Limited is unlisted.

What is the capital structure of De Generic Bio-Tech Private Limited?

The authorized capital of De Generic Bio-Tech Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

What is the compliance status of De Generic Bio-Tech Private Limited?

The compliance status of De Generic Bio-Tech Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available